Key Takeaways Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda,…
Read More »Merck
KEY TAKEAWAYS German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks…
Read More »Key Takeaways U.S. equities rose at midday, lifted by tech shares that sent the Nasdaq 1% higher. Palantir Technologies shares…
Read More »Key Takeaways Merck shares fell sharply Tuesday morning after the drugmaker’s profits and 2025 outlook fell short of estimates. Revenue…
Read More »RFK Jr. made $856,559 in referral fees from the law firm Wisner Baum, which is suing Merck over claims its…
Read More »